The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
Open accessAbstract
MicroRNA (miRNA) levels in serum have recently emerged as potential novel biomarkers for various diseases. miRNAs are routinely measured by standard quantitative real-time PCR (qPCR); however, the high sensitivity of qPCR demands appropriate normalization to correct for nonbiological variation. Presently, RNU6B (U6) is used for data normalization of circulating miRNAs in many studies. However, it was suggested that serum levels of U6 themselves might differ between individuals. Therefore, no consensus has been reached on the best normalization strategy in ‘circulating miRNA’. We analyzed U6 levels as well as levels of spiked-in SV40-RNA in sera of 44 healthy volunteers, 203 intensive care unit patients and 64 patients with liver fibrosis. Levels of U6 demonstrated a high variability in sera of healthy donors, patients with critical illness and liver fibrosis. This high variability could also be confirmed in sera of mice after the cecal ligation and puncture procedure. Most importantly, levels of circulating U6 were significantly upregulated in sera of patients with critical illness and sepsis compared with controls and correlated with established markers of inflammation. In patients with liver fibrosis, U6 levels were significantly downregulated. In contrast, levels of spiked-in SV40 displayed a significantly higher stability both in human cohorts (healthy, critical illness, liver fibrosis) and in mice. Thus, we conclude that U6 levels in the serum are dysregulated in a disease-specific manner. Therefore, U6 should not be used for data normalization of circulating miRNAs in inflammatory diseases and previous studies using this approach should be interpreted with caution. Further studies are warranted to identify specific regulatory processes of U6 levels in sepsis and liver fibrosis. The U6 non-coding RNA is variably expressed in the blood serum of people with different diseases so is not appropriate as a reference to quantify levels of microRNA biomarkers. In principle, U6 is useful only as a normalization control if it is stably regulated in both healthy and diseased tissues. To test this, Tom Luedde and colleagues at University Hospital RWTH Aachen, Germany, measured levels of circulating U6 RNA in 203 patients admitted to a hospital intensive care unit, 64 individuals with liver fibrosis and 44 healthy volunteers. They found that, compared to the healthy controls, U6 levels were elevated in people with critical illness and diminished in people with liver fibrosis. Given the disease-specific expression pattern, the authors conclude that U6 should not be used as a benchmark against which to measure other microRNA biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel and universal method for microRNA RT-qPCR data normalization
Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., & Vandesompele, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-6-r64 · Cited by 1,079
Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
Zhang, Y., Jia, Y., Zheng, R., Guo, Y., Wang, Y., Guo, H., Fei, M., & Sun, S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147850 · Cited by 415
Cited by
Data Normalization Strategies for MicroRNA Quantification
Schwarzenbach, H., da Silva, A. M., Calin, G., & Pantel, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239459 · Cited by 468
Clinical utility of circulating non-coding RNAs — an update
Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0035-x · Cited by 450
Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
Cheng, G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.001 · Cited by 334
Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR
Marabita, F., de Candia, P., Torri, A., Tegnér, J., Abrignani, S., & Rossi, R. L. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv056 · Cited by 266
Circulating MicroRNAs as Biomarkers for Sepsis
Benz, F., Roy, S., Trautwein, C., Roderburg, C., & Luedde, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010078 · Cited by 257
Self-citation
Metadata
- Authors
- Benz, F., Roderburg, C., Vargas Cardenas, D., Vucur, M., Gautheron, J., Koch, A., Zimmermann, H., Janssen, J., Nieuwenhuijsen, L., Luedde, M., Frey, N., Tacke, F., Trautwein, C., & Luedde, T.
- Venue
- Experimental & Molecular Medicine
- Published
- 2013-09-20
- Volume
- 45
- Issue
- 9
- Pages
- e42-e42
- ISSN
- 1226-3613 (ISSN-L)
- 2092-6413
- OpenAlex
- W1972471022
- Cited by
- 173
- References
- 2
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. https://app.cochat.ai/papers/10.1038/emm.2013.81
- The paper
- Benz, F., Roderburg, C., Vargas Cardenas, D., Vucur, M., Gautheron, J., Koch, A., Zimmermann, H., Janssen, J., Nieuwenhuijsen, L., Luedde, M., Frey, N., Tacke, F., Trautwein, C., & Luedde, T. (2013). U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2013.81
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.